AstraZeneca, Lupin Soothe Nexium Patent Fight
Pharmaceutical giants AstraZeneca AB, Merck Sharp & Dohme Corp. and KBI Inc. reached a settlement Thursday with Indian drugmaker Lupin Ltd. in a patent dispute over stomach acid reflux drug Nexium....To view the full article, register now.
Already a subscriber? Click here to view full article